ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,135Hybrid

Jpad-Journal of Prevention of Alzheimers Disease

Abbreviation (ISO):JPAD-J PREV ALZHEIM
•
Identifier (ISSN):2274-5807(Print)/2426-0266(Online)
•
Publisher:EDITIONS SERDI
Clarivate IF (2026)
6.7↓ -1.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Jpad-Journal of Prevention of Alzheimers Disease

WoS Q1
258113.1520204.6720215.0220226.420238.520247.820256.72026
Annual Impact Factor Metric
Current (2026):6.7
Scopus SJR & RankScopus Q1
2.269
#1,135

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
48

48 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
55articles/year
99.79% Gold OA•85.54% Original Research

Aims & Scope

Jpad-Journal of Prevention of Alzheimers Disease (abbr: JPAD-J PREV ALZHEIM, ISSN: 2274-5807) is a peer-reviewed international scholarly journal in the field of CLINICAL NEUROLOGY, published by EDITIONS SERDI in France. The periodical holds a Journal Impact Factor (JIF) of 6.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.269 (Q1), an H-index of 48.

Topics Covered (Recognized by AI)
Medicine97.4%Internal medicine92.8%Pathology91.6%Biology84.9%Disease82.3%Psychology78.7%Psychiatry58.2%Neuroscience55%Dementia52.2%Cognition40%Mathematics36.5%Gerontology32.7%Statistics31.7%Bioinformatics30.1%Alzheimer's disease29.5%Chemistry26.5%Clinical trial26.5%Surgery25.7%Sociology24.7%Biochemistry20.3%Nursing20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CLINICAL NEUROLOGY

Q1
Rank27/296
IndexSCIE
JCISCIE2026

CLINICAL NEUROLOGY

Q1
Rank18/296
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.7
Articles / Year203
Total Citations148
2025
IF7.8
Articles / Year301
Total Citations2,090
2024
IF8.5
Articles / Year170
Total Citations1,999
2023
IF6.4
Articles / Year133
Total Citations3,006
2022
IF5.02
Articles / Year109
Total Citations3,639

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,135Scopus Q1SCImago Profile
Scopus Coverage:2014, 2017-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
2.269

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.04

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,851 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,878
3-Year Documents420
Citable Documents372

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate47.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Neurology (clinical)Q1
Psychiatry and Mental HealthQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CLINICAL NEUROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Jpad-Journal of Prevention of Alzheimers Disease (abbr: JPAD-J PREV ALZHEIM, ISSN: 2274-5807) is a peer-reviewed international scholarly journal in the field of CLINICAL NEUROLOGY, published by EDITIONS SERDI in France. The periodical holds a Journal Impact Factor (JIF) of 6.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.269 (Q1), an H-index of 48.

The journal enforces rigorous peer evaluation with an annual output of approximately 55 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,851 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
EDITIONS SERDI
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEPubMed
Editorial Address
320 RUE SAINT-HONORE, PARIS, FRANCE, 75001

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7b034645-130e-4f02-8d64-a3a5bcb4d388
Database Updated: 2026-10-01